CFN
NTLA icon

Cordasco Financial Network’s Intellia Therapeutics NTLA Stock Holding History

Cordasco Financial Network’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$3K Hold
55
– – ﹤0.01% 507
2022
Q1 		$4K Buy
+55
New +$4.66K ﹤0.01% 475

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cordasco Financial Network's NTLA Position: Q2 2022 in Review

Cordasco Financial Network held its Intellia Therapeutics (NTLA) position steady in Q2 2022 at 55 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #507.

Cordasco Financial Network first reported a position in NTLA in Q1 2022 and has held it in 2 quarters since. The position peaked at $4K in Q1 2022. 301 funds tracked by Wall St. Rank hold NTLA as of Q2 2022.

  • Cordasco Financial Network held 55 shares of Intellia Therapeutics worth $3K as of Q2 2022.
  • Cordasco Financial Network left its Intellia Therapeutics share count unchanged in Q2 2022.
  • Intellia Therapeutics made up ﹤0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #507 holding.
  • Cordasco Financial Network first reported a position in Intellia Therapeutics in Q1 2022 and has held it in 2 quarters since.
  • Cordasco Financial Network's Intellia Therapeutics position peaked at $4K in Q1 2022.
  • 301 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.